Beam Therapeutics Inc
BEAMNASDAQStock · Data from SEC EDGAR 13F · Held by 4 of 87 tracked investors
Beam Therapeutics Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth70
- Profitability5
- Quality20
- Debt100
- Stability8
- ✓It has more cash than debt.
- ✓Revenue grew 31.9% a year over 3 years.
- ✓The analysts' average target is 109% above the price.
- !The company is loss-making: net profit is negative.
- !In some year revenue fell sharply.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 16.2×
- EV/EBITDA
- -4.1×
Is the company growing?
GrowingRevenue over 3 years grew 31.9% a year. Last year -94.2%.
Does it make money?
Loss-makingNet margin: -55.4%.
Is it financially healthy?
YesEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 4 Aug 2026 | -1.18 | -1.00 | -18% |
| Mar 2026 | 7 May 2026 | -0.91 | -0.87 | -4.6% |
| Dec 2025 | 24 Feb 2026 | -0.10 | -1.13 | +91.2% |
| Sep 2025 | 4 Nov 2025 | -1.10 | -0.98 | -12.2% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart BEAM
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
4CW Cathie Wood ARK Investment Management | 2.28% |
SD Stanley Druckenmiller Duquesne Family Office | 0.1% |
JS Jim Simons Renaissance Technologies | 0.02% |
Šn Švýcarská národní banka Swiss National Bank | 0% |
Frequently asked questions
How much is Beam Therapeutics Inc (BEAM) stock?
Beam Therapeutics Inc shares trade at $24.90, +4.67% over the last trading day. The price is delayed.
What is the market cap of Beam Therapeutics Inc?
The market cap of Beam Therapeutics Inc is about $2.6B.
Which big investors hold Beam Therapeutics Inc?
According to the latest 13F filings, 4 of 87 tracked investors hold Beam Therapeutics Inc, for example Cathie Wood, Stanley Druckenmiller, Jim Simons.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.